{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:17:37Z","timestamp":1778253457403,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T00:00:00Z","timestamp":1456099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13402-016-0274-8","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T16:28:45Z","timestamp":1456158525000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Tumor-specific promoter-driven adenoviral therapy for insulinoma"],"prefix":"10.1007","volume":"39","author":[{"given":"Alan Wei-Shun","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiachen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Breslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"key":"274_CR1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1445-2197.1998.tb04714.x","volume":"68","author":"CA Proye","year":"1998","unstructured":"C. A. Proye, Endocrine tumours of the pancreas: an update. Aust. N. Z. J. Surg. 68, 90\u2013100 (1998)","journal-title":"Aust. N. Z. J. Surg."},{"key":"274_CR2","doi-asserted-by":"crossref","unstructured":"C. Yu, M. Wang, Z. Li, J. Xiao, F. Peng, X. Guo, Y. Deng, J. Jiang, C. Sun, MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1. Cell. Oncol. 38, 173\u2013181 (2015)","DOI":"10.1007\/s13402-014-0200-x"},{"key":"274_CR3","doi-asserted-by":"crossref","first-page":"15252","DOI":"10.1016\/S0021-9258(18)42173-4","volume":"267","author":"Y Goto","year":"1992","unstructured":"Y. Goto, M.G. DeSilva, A. Toscani, B.S. Prabhakar, A.L. Notkins, M.S. Lan, A novel human insulinoma-associated cDNA, IA-1, encodes a protein with zinc-finger DNA-binding motifs. J. Biol. Chem. 267, 15252\u201315257 (1992)","journal-title":"J. Biol. Chem."},{"key":"274_CR4","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1096\/fj.08-125971","volume":"23","author":"MS Lan","year":"2009","unstructured":"M. S. Lan, M. B. Breslin, Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J. 23, 2024\u20132033 (2009)","journal-title":"FASEB J."},{"key":"274_CR5","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.381806","volume":"20","author":"MS Gierl","year":"2006","unstructured":"M. S. Gierl, N. Karoulias, H. Wende, M. Strehle, C. Birchmeier, The Zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev. 20, 2465\u20132478 (2006)","journal-title":"Genes Dev."},{"key":"274_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1242\/dev.011783","volume":"135","author":"H Wildner","year":"2008","unstructured":"H. Wildner, M. S. Gierl, M. Strehle, P. Pla, C. Birchmeier, Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage. Development 135, 473\u2013481 (2008)","journal-title":"Development"},{"key":"274_CR7","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1089\/hum.2008.168","volume":"20","author":"HW Wang","year":"2009","unstructured":"H. W. Wang, M. B. Breslin, C. Chen, V. Akerstrom, Q. Zhong, M. S. Lan, INSM1-promoter driven adenoviral HSV thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors. Human Gene Ther. 20, 1308\u20131318 (2009)","journal-title":"Human Gene Ther."},{"key":"274_CR8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/cgt.2012.66","volume":"19","author":"V Akerstrom","year":"2012","unstructured":"V. Akerstrom, C. Chen, M. S. Lan, M. B. Breslin, Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas. Cancer Gene Ther. 19, 828\u2013838 (2012)","journal-title":"Cancer Gene Ther."},{"key":"274_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/hum.1990.1.2-125","volume":"1","author":"FI Moolten","year":"1990","unstructured":"F. I. Moolten, J. M. Wells, R. A. Heyman, R. M. Evans, Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Human Gene Ther. 1, 125\u2013134 (1990)","journal-title":"Human Gene Ther."},{"key":"274_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/334124a0","volume":"334","author":"P Whyte","year":"1988","unstructured":"P. Whyte, K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, E. Harlow, Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124\u2013129 (1988)","journal-title":"Nature"},{"key":"274_CR11","doi-asserted-by":"crossref","unstructured":"W. C. Ch'ng, N. Abd-Aziz, M. H. Ong, E. J. Stanbridge, N. Shafee, Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK\/NF-kappaB\/IkappaBalpha pathway. Cell. Oncol. 38, 279\u2013288 (2015)","DOI":"10.1007\/s13402-015-0229-5"},{"key":"274_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"H. Mizuguchi, Z. Xu, A. Ishii-Watabe, E. Uchida, T. Hayakawa, IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol. Ther. 1, 376\u2013382 (2000)","journal-title":"Mol. Ther."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-016-0274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-016-0274-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-016-0274-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T21:26:54Z","timestamp":1654378014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-016-0274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1007\/s13402-016-0274-8","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]}}}